Terms: = Gastric cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
223 results:
1. Predictive Value of a New Muscle Parameter in Patients with Resectable gastric cancer: A Pooled Analysis of Three Prospective Trials.
Zhong Q; Huang JB; Lu J; Xue LW; Lin GT; Xie JW; Lin JX; Zheng CH; Huang CM; Li P
Ann Surg Oncol; 2024 May; 31(5):3005-3016. PubMed ID: 38270825
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of
Mileva M; Marin G; Levillain H; Artigas C; Van Bogaert C; Marin C; Danieli R; Deleporte A; Picchia S; Stathopoulos K; Jungels C; Vanderlinden B; Paesmans M; Ameye L; Critchi G; Taraji-Schiltz L; Velghe C; Wimana Z; Bali M; Hendlisz A; Flamen P; Karfis I
J Nucl Med; 2024 Feb; 65(2):236-244. PubMed ID: 38164576
[TBL] [Abstract] [Full Text] [Related]
3. Value of
Miao Y; Feng R; Yu T; Guo R; Zhang M; Wang Y; Hai W; Shangguan C; Zhu Z; Li B
J Nucl Med; 2024 Feb; 65(2):213-220. PubMed ID: 38164574
[TBL] [Abstract] [Full Text] [Related]
4. Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
Kim HC; Yang E; Lee S; Oh J; Lee M; Lee C; Ha KS; Lee WS; Jang IJ; Yu KS
Invest New Drugs; 2024 Feb; 42(1):80-88. PubMed ID: 38099989
[TBL] [Abstract] [Full Text] [Related]
5. Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
Seckinger A; Majocchi S; Moine V; Nouveau L; Ngoc H; Daubeuf B; Ravn U; Pleche N; Calloud S; Broyer L; Cons L; Lesnier A; Chatel L; Papaioannou A; Salgado-Pires S; Krämer S; Gockel I; Lordick F; Masternak K; Poitevin Y; Magistrelli G; Malinge P; Shang L; Kallendrusch S; Strein K; Hose D
J Hematol Oncol; 2023 Dec; 16(1):117. PubMed ID: 38087365
[TBL] [Abstract] [Full Text] [Related]
6.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
7. gastric cancer incidence based on endoscopic Kyoto classification of gastritis.
Toyoshima O; Nishizawa T; Yoshida S; Matsuno T; Fujisawa G; Toyoshima A; Ebinuma H; Fujishiro M; Saito Y; Suzuki H
World J Gastroenterol; 2023 Aug; 29(31):4763-4773. PubMed ID: 37664152
[TBL] [Abstract] [Full Text] [Related]
8. The use of indocyanine green (ICYG) angiography intraoperatively to evaluate gastric conduit perfusion during esophagectomy: does it impact surgical decision-making?
LeBlanc G; Takahashi C; Huston J; Shridhar R; Meredith K
Surg Endosc; 2023 Nov; 37(11):8720-8727. PubMed ID: 37530987
[TBL] [Abstract] [Full Text] [Related]
9. Despite warnings, co-medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH-dependence, minimizing undesirable drug-drug interactions.
Larfors G; Andersson P; Jesson G; Liljebris C; Brisander M; Lennernäs H; Stenke L
Eur J Haematol; 2023 Oct; 111(4):644-654. PubMed ID: 37503797
[TBL] [Abstract] [Full Text] [Related]
10. Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era.
Dermawan JK; Kelly C; Gao Z; Smith S; Jadeja B; Singer S; Tap WD; Chi P; Antonescu CR
Clin Cancer Res; 2023 Oct; 29(19):3974-3985. PubMed ID: 37477937
[TBL] [Abstract] [Full Text] [Related]
11. Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer.
Zhang M; Yang H; Fu T; Meng M; Feng Y; Qu C; Li Z; Xing X; Li W; Ye M; Li S; Bu Z; Jia S
Mol Oncol; 2023 Sep; 17(9):1930-1942. PubMed ID: 37356061
[TBL] [Abstract] [Full Text] [Related]
12. Accurate Preoperative Evaluation of the Location of Esophagogastric Junction Adenocarcinoma Using Positron Emission Tomography-Computed Tomography.
Wada N; Kurokawa Y; Takahashi T; Saito T; Yamamoto K; Yamashita K; Tanaka K; Makino T; Nakajima K; Tatsumi M; Eguchi H; Doki Y
Am Surg; 2023 Dec; 89(12):6005-6012. PubMed ID: 37312037
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants.
Sugimoto M; Murata M; Kawai T
World J Gastroenterol; 2023 May; 29(19):2916-2931. PubMed ID: 37274799
[TBL] [Abstract] [Full Text] [Related]
14. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
15. Perfusion assessment by fluorescence time curves in esophagectomy with gastric conduit reconstruction: a prospective clinical study.
Joosten JJ; Slooter MD; van den Elzen RM; Bloemen PR; Gisbertz SS; Eshuis WJ; Daams F; de Bruin DM; van Berge Henegouwen MI
Surg Endosc; 2023 Aug; 37(8):6343-6352. PubMed ID: 37208482
[TBL] [Abstract] [Full Text] [Related]
16. Association of dynamic contrast-enhanced MRI and
Withey SJ; Owczarczyk K; Grzeda MT; Yip C; Deere H; Green M; Maisey N; Davies AR; Cook GJ; Goh V;
Eur J Surg Oncol; 2023 Oct; 49(10):106934. PubMed ID: 37183047
[TBL] [Abstract] [Full Text] [Related]
17. Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk.
Maeda Y; Kobashi K; Sato Y; Tamamura H; Yamamoto K; Matsushita K; Sasaki M; Tatebe H; Asahi T; Matsumoto S; Takamatsu S; Miyazaki K; Fujimoto R; Uchinami Y; Katoh N; Aoyama H
Med Phys; 2023 Jun; 50(6):3274-3288. PubMed ID: 37099416
[TBL] [Abstract] [Full Text] [Related]
18. First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection.
Wang S; Qi C; Ding J; Li D; Zhang M; Ji C; Jiang F; Teng F; Yu J; Qian X; Wang F; Shen L; Gao J; Yang Z; Zhang C; Zhu H
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2802-2817. PubMed ID: 37099132
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of [
Du T; Zhang S; Cui XM; Hu RH; Wang HY; Jiang JJ; Zhao J; Zhong L; Jiang XH
Can J Gastroenterol Hepatol; 2023; 2023():6351330. PubMed ID: 37090103
[TBL] [Abstract] [Full Text] [Related]
20. Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An
Piscitelli J; Hens B; Tomaszewska I; Wollenberg L; Litwiler K; McAllister M; Reddy M
Mol Pharm; 2023 May; 20(5):2589-2599. PubMed ID: 37037186
[TBL] [Abstract] [Full Text] [Related]
[Next]
